Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant
- PMID: 8751895
- PMCID: PMC174259
- DOI: 10.1128/iai.64.9.3532-3536.1996
Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant
Abstract
A blood-stage malaria antigen comprising the C terminus of merozoite surface protein 1 fused to glutathione S-transferase, combined with an adjuvant formulation containing squalane, Tween 80, and pluronic L121 (AF), administered subcutaneously protected mice against death from a lethal Plasmodium yoelii infection. The protection induced by this antigen-adjuvant combination was compared with that induced by the antigen plus saponin in terms of survival from the lethal infection and clearance of parasitemia. The levels of gamma interferon and interleukin-4 in spleens were measured as indicators of Th1 and Th2 cell activation, and antibody classes and subclasses were determined by immunofluorescence. With a 10-micrograms dose of antigen and AF as adjuvant, all mice recovered, but with saponin as the adjuvant, there were only a few survivors. With 30 micrograms of antigen plus AF, the peak parasitemias were 10-fold lower than those with 10 micrograms; with saponin, survival was slightly improved. The levels of both gamma interferon and interleukin-4 rose more rapidly and to higher levels with AF as the adjuvant than with saponin, and the same was true for immunoglobulin G1 (IgG1), IgG2a, and IgG2b subclasses. Thus, in terms of both cytokine production and antibody levels, AF is a more potent adjuvant for a malaria vaccine than is saponin.
Similar articles
-
A novel adjuvant for use with a blood-stage malaria vaccine.Vaccine. 1995 Oct;13(14):1316-9. doi: 10.1016/0264-410x(95)00025-v. Vaccine. 1995. PMID: 8585286
-
Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.Infect Immun. 1996 Jul;64(7):2602-8. doi: 10.1128/iai.64.7.2602-2608.1996. Infect Immun. 1996. PMID: 8698485 Free PMC article.
-
Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.J Exp Med. 1998 Sep 7;188(5):845-54. doi: 10.1084/jem.188.5.845. J Exp Med. 1998. PMID: 9730886 Free PMC article.
-
Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.Infect Immun. 2002 Feb;70(2):692-701. doi: 10.1128/IAI.70.2.692-701.2002. Infect Immun. 2002. PMID: 11796601 Free PMC article.
-
Immunity to erythrocytic stages of malarial parasites.Am J Trop Med Hyg. 1994;50(4 Suppl):27-32. doi: 10.4269/ajtmh.1994.50.27. Am J Trop Med Hyg. 1994. PMID: 7909653 Review.
Cited by
-
Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature.Infect Immun. 2000 Sep;68(9):5364-76. doi: 10.1128/IAI.68.9.5364-5376.2000. Infect Immun. 2000. PMID: 10948166 Free PMC article.
-
Immune responses of NIH mice infected with avirulent and virulent strains of Plasmodium chabaudi adami single and mixed infections.Korean J Parasitol. 2010 Mar;48(1):23-33. doi: 10.3347/kjp.2010.48.1.23. Epub 2010 Mar 18. Korean J Parasitol. 2010. PMID: 20333282 Free PMC article.
-
Immune responses of mice with different genetic backgrounds to improved multiepitope, multitarget malaria vaccine candidate antigen FALVAC-1A.Clin Vaccine Immunol. 2008 Nov;15(11):1674-83. doi: 10.1128/CVI.00164-08. Epub 2008 Sep 10. Clin Vaccine Immunol. 2008. PMID: 18784343 Free PMC article.
-
CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites.Infect Immun. 2004 Oct;72(10):5768-74. doi: 10.1128/IAI.72.10.5768-5774.2004. Infect Immun. 2004. PMID: 15385476 Free PMC article.
-
Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1.Infect Immun. 1998 Nov;66(11):5329-36. doi: 10.1128/IAI.66.11.5329-5336.1998. Infect Immun. 1998. PMID: 9784540 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials